{{ 'fb_in_app_browser_popup.desc' | translate }} {{ 'fb_in_app_browser_popup.copy_link' | translate }}
{{ 'in_app_browser_popup.desc' | translate }}

If you've been following health and longevity trends, you've almost certainly come across NMN (Nicotinamide Mononucleotide). But what exactly is NMN? Are the anti-aging claims backed by real science — or is it all hype? And why did the U.S. FDA effectively pull it from supplement shelves? In this article, we break down how NMN works, its relationship to NAD+, its legal status, and what you should know before buying.
Before understanding NMN, it helps to first understand NAD+ (Nicotinamide Adenine Dinucleotide) — a coenzyme naturally present in every cell of the human body. NAD+ plays a critical role in energy metabolism, DNA repair, and the maintenance of cellular function. Researchers have found that NAD+ levels naturally decline with age, which is linked to increased cellular aging, reduced energy levels, and higher disease risk. As a result, boosting NAD+ has become one of the most active areas in anti-aging research.

NAD+ molecules are too large to pass directly into cells. NMN molecules are significantly smaller, allowing them to be absorbed more efficiently. Once inside the body, NMN is converted into NAD+ through a biological process — making it an effective precursor for raising and maintaining NAD+ levels.
NMN is a direct precursor to NAD+ and is naturally produced in the body in small amounts. After ingestion, NMN is rapidly transported into cells via specialized carrier proteins and converted to NAD+, which then participates in a wide range of metabolic processes. Because NAD+ cannot enter cells directly due to its molecular size, NMN serves as the practical delivery vehicle for restoring NAD+ levels within cells.

The regulatory situation around NMN in the U.S. stems from a specific drug application. A company called Metro International Biotech — co-founded by prominent longevity researcher Dr. David Sinclair — submitted an Investigational New Drug (IND) application for MIB-626, a pharmaceutical-grade NMN-based drug. Following this submission, the FDA ruled in 2022 that NMN could no longer be marketed as a dietary supplement, as it was now under investigation as a drug.
Importantly, this ruling does not mean NMN is unsafe or ineffective — it is a legal and regulatory classification issue, not a safety finding.
The situation has since been actively contested:
Under current Taiwanese regulations, most commercially available NMN is chemically synthesized, which means it cannot be legally sold as a supplement in Taiwan. Only NMN extracted from natural food or plant sources is permitted. However, plant-derived NMN varies considerably in purity, so consumers should carefully verify the source, quality, and third-party testing certificates before purchasing to avoid adulterated or low-quality products.
NMN is not a scam — but it is often overhyped. The current body of research is promising but still maturing. Most studies to date have been conducted in animal models, with results suggesting NMN can slow aging processes and support metabolic health. However, human clinical data remain limited, and long-term safety and efficacy have not yet been established at a scale sufficient to make broad public health recommendations.
Consumers should be cautious of unsubstantiated claims such as "reversing aging" or "curing chronic disease." These are not supported by current evidence and are red flags for irresponsible marketing.
If you're interested in NMN, NADH is another key ingredient worth knowing. NADH is the reduced form of NAD+ and plays a distinct role in regulating physiological functions. In our next article, we'll explore the differences and connections between NMN and NADH in depth — stay tuned.
References:
The NPA Files Lawsuit Against the FDA Over NMN Ban
You may be interested: